Quest Diagnostics, Inc. (DGX) Tops Q3 EPS by 7c; Guides FY11 EPS Above Views
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $215.72 -0.14%
EPS Growth %: +7.6%
Financial Fact:
Total non-operating expenses, net: -33M
Today's EPS Names:
CRMT, More
EPS Growth %: +7.6%
Financial Fact:
Total non-operating expenses, net: -33M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q3 EPS of $1.18, $0.07 better than the analyst estimate of $1.11. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.89 billion.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.30-$4.35, versus the consensus of $4.21. Sees revenues growing 1.5%, unchanged from previous guidance
Quest Diagnostics, Inc. sees FY2011 EPS of $4.30-$4.35, versus the consensus of $4.21. Sees revenues growing 1.5%, unchanged from previous guidance
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Creative Medical Technology issues mid-year pipeline update
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
